Role of Muscle c-Jun NH₂-Terminal Kinase 1 in Obesity-Induced Insulin Resistance

REFERENCES

• Aguirre, V., T. Uchida, L. Yenush, R. Davis, and M. F. White. 2000. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J. Biol. Chem. 275:9047–9054.
   PubMed Web of Science ®Google Scholar
• Bennett, B. L., Y. Satoh, and A. J. Lewis. 2003. JNK: a new therapeutic target for diabetes. Curr. Opin. Pharmacol. 3:420–425.
   PubMed Web of Science ®Google Scholar
• Bruning, J. C., M. D. Michael, J. N. Winnay, T. Hayashi, D. Horsch, D. Accili, L. J. Goodyear, and C. R. Kahn. 1998. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell 2:559–569.
   PubMed Web of Science ®Google Scholar
• Das, M., F. Jiang, H. K. Sluss, C. Zhang, K. M. Shokat, R. A. Flavell, and R. J. Davis. 2007. Suppression of p53-dependent senescence by the JNK signal transduction pathway. Proc. Natl. Acad. Sci. U. S. A. 104:15759–15764.
   PubMed Web of Science ®Google Scholar
• Desvergne, B. 2008. PPARdelta/beta: the lobbyist switching macrophage allegiance in favor of metabolism. Cell Metab. 7:467–469.
   PubMed Web of Science ®Google Scholar
• Dong, C., D. D. Yang, M. Wysk, A. J. Whitmarsh, R. J. Davis, and R. A. Flavell. 1998. Defective T cell differentiation in the absence of Jnk1. Science 282:2092–2095.
   PubMed Web of Science ®Google Scholar
• Hirosumi, J., G. Tuncman, L. Chang, C. Z. Gorgun, K. T. Uysal, K. Maeda, M. Karin, and G. S. Hotamisligil. 2002. A central role for JNK in obesity and insulin resistance. Nature 420:333–336.
   PubMed Web of Science ®Google Scholar
• Kahn, S. E., R. L. Hull, and K. M. Utzschneider. 2006. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444:840–846.
   PubMed Web of Science ®Google Scholar
• Kaneto, H., Y. Nakatani, T. Miyatsuka, D. Kawamori, T. A. Matsuoka, M. Matsuhisa, Y. Kajimoto, H. Ichijo, Y. Yamasaki, and M. Hori. 2004. Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide. Nat. Med. 10:1128–1132.
   PubMed Web of Science ®Google Scholar
• Kim, H. J., T. Higashimori, S. Y. Park, H. Choi, J. Dong, Y. J. Kim, H. L. Noh, Y. R. Cho, G. Cline, Y. B. Kim, and J. K. Kim. 2004. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 53:1060–1067.
   PubMed Web of Science ®Google Scholar
• Lee, Y. H., J. Giraud, R. J. Davis, and M. F. White. 2003. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J. Biol. Chem. 278:2896–2902.
   PubMed Web of Science ®Google Scholar
• Mora, A., K. Sakamoto, E. J. McManus, and D. R. Alessi. 2005. Role of the PDK1-PKB-GSK3 pathway in regulating glycogen synthase and glucose uptake in the heart. FEBS Lett. 579:3632–3638.
   PubMed Web of Science ®Google Scholar
• Morino, K., S. Neschen, S. Bilz, S. Sono, D. Tsirigotis, R. M. Reznick, I. Moore, Y. Nagai, V. Samuel, D. Sebastian, M. White, W. Philbrick, and G. I. Shulman. 2008. Muscle-specific IRS-1 Ser→Ala transgenic mice are protected from fat-induced insulin resistance in skeletal muscle. Diabetes 57:2644–2651.
   PubMedGoogle Scholar
• Perseghin, G., K. Petersen, and G. I. Shulman. 2003. Cellular mechanism of insulin resistance: potential links with inflammation. Int. J. Obes. Relat. Metab. Disord. 27 (Suppl. 3):S6–S11.
   PubMed Web of Science ®Google Scholar
• Sabio, G., J. Cavanagh-Kyros, H. J. Ko, D. Y. Jung, S. Gray, J. Y. Jun, T. Barrett, A. Mora, J. K. Kim, and R. J. Davis. 2009. Prevention of steatosis by hepatic JNK1. Cell Metab. 10.1016/j.cmet.2009.09.007.
   Google Scholar
• Sabio, G., M. Das, A. Mora, Z. Zhang, J. Y. Jun, H. J. Ko, T. Barrett, J. K. Kim, and R. J. Davis. 2008. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science 322:1539–1543.
   PubMed Web of Science ®Google Scholar
• Savage, D. B., K. F. Petersen, and G. I. Shulman. 2007. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol. Rev. 87:507–520.
   PubMed Web of Science ®Google Scholar
• Stebbins, J. L., S. K. De, T. Machleidt, B. Becattini, J. Vazquez, C. Kuntzen, L. H. Chen, J. F. Cellitti, M. Riel-Mehan, A. Emdadi, G. Solinas, M. Karin, and M. Pellecchia. 2008. Identification of a new JNK inhibitor targeting the JNK-JIP interaction site. Proc. Natl. Acad. Sci. U. S. A. 105:16809–16813.
   PubMed Web of Science ®Google Scholar
• Wang, H., and R. H. Eckel. 2009. Lipoprotein lipase: from gene to obesity. Am. J. Physiol. Endocrinol. Metab. 297:E271–E288.
   PubMed Web of Science ®Google Scholar
• Wang, H., L. A. Knaub, D. R. Jensen, D. Y. Jung, E. G. Hong, H. J. Ko, A. M. Coates, I. J. Goldberg, B. A. de la Houssaye, R. C. Janssen, C. E. McCurdy, S. M. Rahman, C. S. Choi, G. I. Shulman, J. K. Kim, J. E. Friedman, and R. H. Eckel. 2009. Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues. Diabetes 58:116–124.
   PubMed Web of Science ®Google Scholar
• Weston, C. R., and R. J. Davis. 2007. The JNK signal transduction pathway. Curr. Opin. Cell Biol. 19:142–149.
   PubMed Web of Science ®Google Scholar
• Whitmarsh, A. J., and R. J. Davis. 2001. Analyzing JNK and p38 mitogen-activated protein kinase activity. Methods Enzymol. 332:319–336.
   PubMedGoogle Scholar
• Yang, R., and J. M. Trevillyan. 2008. c-Jun N-terminal kinase pathways in diabetes. Int. J. Biochem. Cell Biol. 40:2702–2706.
   PubMed Web of Science ®Google Scholar